Teen Use of Wegovy Surges 50% in 2024

A noteworthy shift is unfolding in teen healthcare: the weight-loss drug Wegovy—a GLP‑1 therapy by Novo Nordisk—has seen a dramatic 50% rise in prescriptions among U.S. adolescents over the past year. 📊 By the Numbers In 2023, 9.9 teens per 100,000 began Wegovy...